CALCITONIN NEGATIVE MEDULLARY THYROID CARCINOMA
Abstract
Medullary thyroid cancer (MTC) is a neuroendocrine neoplasm that arises from parafollicular C cells. Basal and stimulated calcitonin are used in screening, differential diagnosis, assessment of response to treatment and monitoring of MTC. Calcitonin-negative MTC (MTC with normal values of basal and stimulated calcitonin) is extremely rare (49 cases described in the literature). In the absence of appropriate disease predictors, the diagnosis of calcitonin-negative MTC is not easy and is often delayed.
A patient with a nodule in the thyroid gland and diskettely elevated calcitonin values is shown. Calcium gluconate stimulation test and carcinoembryonic antigen were normal, and the existence of MTC was ruled out. After a year, the patient notices pain in the lower part of the spinal column. He is referred to rehabilitation treatment, which does not give significant results. Laboratory work-up determines elevated values of parathyroid hormone, scintigraphy shows an enlarged hyperactive lower left parathyroid gland, and thyroidectomy and lower left parathyroidectomy with lymphadenectomy are performed. Pathohistological examination revealed MTC pT1aNxMx. Immunohistochemical analysis was negative for calcitonin and thyroglobulin, positive for chromogranin A and thyroid transcription factor 1 (Thyroid transcription factor-1.
Further randomized clinical trials are needed to identify appropriate predictors of calcitonin-negative MTC. Until then, it is necessary to keep in mind the existence of calcitonin-negative MTC that cannot be identified by basal and stimulated calcitonin and carcinoembryonic antigen.
References
7. Toledo SP, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE. Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics (Sao Paulo). 2009;64(7):699-706. Dostupno na: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710445/ 8. Yue W, Zhang Y. Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma. Front. Endocrinol. 2022;13:1025629. Dostupno na: https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.1025629/full 9. Zhou Q, Yue S, Cheng Y, Jin J, Xu H. Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin. Exp Toxicol Pathol. 2017;69:575–9. Dostupno na: https://www.sciencedirect.com/science/article/abs/pii/S0940299316304080?via%3Dihub 10. Frank-Raue K, Machens A, Leidig-Bruckner G, Rondot S, Haag C, Schulze E, et al. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma. Thyroid. 2013;23:294–300. Dostupno na: https://doi.org/10.1210/jc.2005-1429
11. Leboeuf R, Langlois MF, Martin M, Ahnadi CE, Fink GD. Hook Effect” in Calcitonin Immunoradiometric Assay in Patients with Metastatic Medullary Thyroid Carcinoma: Case Report and Review of the Literature, The Journal of Clinical Endocrinology & Metabolism. 2006;91(2):361–364. Dostupno na: https://www.liebertpub.com/doi/10.1089/thy.2012.0236 12. Dora JM, Canalli MH, Capp C, Puñales MK, Vieira JG, Maia AL. Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature. Thyroid. 2008 Aug;18(8):895-9. Dostupno na: https://www.liebertpub.com/doi/10.1089/thy.2007.0231 13. Brutsaert EF, Gersten AJ, Tassler AB, Surks MI. Medullary Thyroid Cancer With Undetectable Serum Calcitonin, The Journal of Clinical Endocrinology & Metabolism.2015 Feb1;100(2):337–341. Dostupno na: https://doi.org/10.1210/jc.2014-3095 14. Redding AH, Levine SN, Fowler MR. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid. 2000;10(10):919–922. Dostupno na: https://www.liebertpub.com/doi/abs/10.1089/thy.2000.10.919 15. Kiriakopoulos A, Giannakis P, Menenakos E. Calcitonin: current concepts and differential diagnosis. Ther Adv Endocrinol Metab. 2022 May 21;13:20420188221099344. Dostupno na: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125613/ 16. Gonzales-Laguado E, Guerra-Miller H, García-Ruiz L, Luna-Abanto J. Intrathyroidal thymic carcinoma misdiagnosed as a medullary thyroid carcinomaCirugía y Cirujanos. 2020;88(S1):35-38. Dostupno na: https://www.scielo.org.mx/pdf/cicr/v88s1/0009-7411-cir-88-Suppl%201-35.pdf
17. S. Kojić Katović, A. Vasilj; Preoperacijska dijagnostika medularnog karcinoma štitnjače s osvrtom na citomorfološke značajke i diferencijalnu dijagnozu primarnih i sekundarnih tumora štitnjače. Acta Med Croatica. 2014;68:383-388. Dostupno na: https://hrcak.srce.hr/file/209793